目次

Table of Contents

Chapter 1. Pan-Genomic & Multi-Gene Panel Testing Market: Methodology and Scope
1.1. Market Segmentation and Scope
1.1.1. Segment Definitions
1.1.1.1. Test
1.1.1.2. Application Segment
1.1.1.3. End Use Segment
1.2. Regional Scope
1.3. Estimates and Forecast Timeline
1.4. Objectives
1.4.1. Objective - 1
1.4.2. Objective - 2
1.4.3. Objective - 3
1.5. Research Methodology
1.6. Information Procurement
1.6.1. Purchased Database
1.6.2. GVR’s Internal Database
1.6.3. Secondary Sources
1.6.4. Primary Research
1.7. Information or Data Analysis
1.7.1. Data Analysis Models
1.8. Market Formulation & Validation
1.9. Model Details
1.9.1. Commodity Flow Analysis
1.10. List of Secondary Sources
1.11. List of Abbreviations

Chapter 2. Pan-Genomic & Multi-Gene Panel Testing Market: Executive Summary
2.1. Market Snapshot
2.2. Test
2.3. Application Snapshot
2.4. End Use Snapshot
2.5. Competitive Landscape Snapshot

Chapter 3. Pan-Genomic & Multi-Gene Panel Testing Market Variables, Trends, & Scope
3.1. Market Segmentation and Scope
3.2. Market Lineage Outlook
3.2.1. Parent Market Outlook
3.2.2. Related/Ancillary Market Outlook
3.3. Market Dynamics
3.4. Market Drivers Analysis
3.4.1. Clinical adoption in oncology and precision medicine
3.4.2. Falling sequencing costs & tech advances
3.4.3. Increasing burden of genetic disorders & rising
3.5. Market Restraint Analysis
3.5.1. Complexity of data interpretation & shortage of skilled genomic specialists
3.5.2. Regulatory challenges, compliance Burdens & lack of standardization
3.6. Porter’s Five Forces Analysis
3.7. PESTLE Analysis
3.8. Pipeline Analysis

Chapter 4. Pan-Genomic & Multi-Gene Panel Testing Market: Test Estimates & Trend Analysis
4.1. Pan-Genomic & Multi-Gene Panel Testing Market: Test Movement Analysis
4.2. Pan-Genomic / Whole Exome Based Panels
4.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.3. Comprehensive Hereditary Disease Panels
4.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.4. Oncology Multi-Gene Panels
4.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.5. Pharmacogenomics (PGx) Panels
4.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Pan-Genomic & Multi-Gene Panel Testing Market: Application Estimates & Trend Analysis
5.1. Pan-Genomic & Multi-Gene Panel Testing Market: Application Movement Analysis
5.2. Oncology
5.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.3. Cardiology & Cardiomyopathy
5.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.4. Neurology and Neurogenetics
5.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.5. Rare & Undiagnosed Genetic Diseases
5.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.6. Reproductive Carrier Screening
5.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.7. Newborn & Pediatric Genomics
5.7.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Pan-Genomic & Multi-Gene Panel Testing Market: End Use Estimates & Trend Analysis
6.1. Pan-Genomic & Multi-Gene Panel Testing Market: End Use Movement Analysis
6.2. Hospital-based Genetic Labs
6.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.3. Independent Diagnostic Labs
6.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.4. Specialty Genomic Centers
6.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5. Others
6.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Pan-Genomic & Multi-Gene Panel Testing Market: Regional Business Analysis
7.1. Regional Market Snapshot
7.2. North America
7.2.1. North America Pan-Genomic & Multi-Gene Panel Testing Market Estimates and Forecast, 2021 - 2033 (USD Million)
7.2.2. U.S.
7.2.2.1. U.S. Pan-Genomic & Multi-Gene Panel Testing Market, 2021 - 2033 (USD Million)
7.2.2.2. Key Country Dynamics
7.2.2.3. Regulatory Framework
7.2.2.4. Reimbursement Scenario
7.2.2.5. Competitive Scenario
7.2.3. Canada
7.2.3.1. Canada Pan-Genomic & Multi-Gene Panel Testing Market, 2021 - 2033 (USD Million)
7.2.3.2. Key Country Dynamics
7.2.3.3. Regulatory Framework
7.2.3.4. Reimbursement Scenario
7.2.3.5. Competitive Scenario
7.2.4. Mexico
7.2.4.1. Mexico Pan-Genomic & Multi-Gene Panel Testing Market, 2021 - 2033 (USD Million)
7.2.4.2. Key Country Dynamics
7.2.4.3. Regulatory Framework
7.2.4.4. Reimbursement Scenario
7.2.4.5. Competitive Scenario
7.3. Europe
7.3.1. Europe Pan-Genomic & Multi-Gene Panel Testing Market, 2021 - 2033 (USD Million)
7.3.2. UK
7.3.2.1. UK Pan-Genomic & Multi-Gene Panel Testing Market, 2021 - 2033 (USD Million)
7.3.2.2. Key Country Dynamics
7.3.2.3. Regulatory Framework
7.3.2.4. Reimbursement Scenario
7.3.2.5. Competitive Scenario
7.3.3. Germany
7.3.3.1. Germany Pan-Genomic & Multi-Gene Panel Testing Market, 2021 - 2033 (USD Million)
7.3.3.2. Key Country Dynamics
7.3.3.3. Regulatory Framework
7.3.3.4. Reimbursement Scenario
7.3.3.5. Competitive Scenario
7.3.4. Spain
7.3.4.1. Spain Pan-Genomic & Multi-Gene Panel Testing Market, 2021 - 2033 (USD Million)
7.3.4.2. Key Country Dynamics
7.3.4.3. Regulatory Framework
7.3.4.4. Reimbursement Scenario
7.3.4.5. Competitive Scenario
7.3.5. France
7.3.5.1. France Pan-Genomic & Multi-Gene Panel Testing Market, 2021 - 2033 (USD Million)
7.3.5.2. Key Country Dynamics
7.3.5.3. Regulatory Framework
7.3.5.4. Reimbursement Scenario
7.3.5.5. Competitive Scenario
7.3.6. Italy
7.3.6.1. Italy Pan-Genomic & Multi-Gene Panel Testing Market, 2021 - 2033 (USD Million)
7.3.6.2. Key Country Dynamics
7.3.6.3. Regulatory Framework
7.3.6.4. Reimbursement Scenario
7.3.6.5. Competitive Scenario
7.3.7. Denmark
7.3.7.1. Denmark Pan-Genomic & Multi-Gene Panel Testing Market, 2021 - 2033 (USD Million)
7.3.7.2. Key Country Dynamics
7.3.7.3. Regulatory Framework
7.3.7.4. Reimbursement Scenario
7.3.7.5. Competitive Scenario
7.3.8. Sweden
7.3.8.1. Sweden Pan-Genomic & Multi-Gene Panel Testing Market, 2021 - 2033 (USD Million)
7.3.8.2. Key Country Dynamics
7.3.8.3. Regulatory Framework
7.3.8.4. Reimbursement Scenario
7.3.8.5. Competitive Scenario
7.3.9. Norway
7.3.9.1. Norway Pan-Genomic & Multi-Gene Panel Testing Market, 2021 - 2033 (USD Million)
7.3.9.2. Key Country Dynamics
7.3.9.3. Regulatory Framework
7.3.9.4. Reimbursement Scenario
7.3.9.5. Competitive Scenario
7.4. Asia Pacific
7.4.1. Asia Pacific Pan-Genomic & Multi-Gene Panel Testing Market, 2021 - 2033 (USD Million)
7.4.2. Japan
7.4.2.1. Japan Pan-Genomic & Multi-Gene Panel Testing Market, 2021 - 2033 (USD Million)
7.4.2.2. Key Country Dynamics
7.4.2.3. Regulatory Framework
7.4.2.4. Reimbursement Scenario
7.4.2.5. Competitive Scenario
7.4.3. China
7.4.3.1. China Pan-Genomic & Multi-Gene Panel Testing Market, 2021 - 2033 (USD Million)
7.4.3.2. Key Country Dynamics
7.4.3.3. Regulatory Framework
7.4.3.4. Reimbursement Scenario
7.4.3.5. Competitive Scenario
7.4.4. India
7.4.4.1. India Pan-Genomic & Multi-Gene Panel Testing Market, 2021 - 2033 (USD Million)
7.4.4.2. Key Country Dynamics
7.4.4.3. Regulatory Framework
7.4.4.4. Reimbursement Scenario
7.4.4.5. Competitive Scenario
7.4.5. South Korea
7.4.5.1. South Korea Pan-Genomic & Multi-Gene Panel Testing Market, 2021 - 2033 (USD Million)
7.4.5.2. Key Country Dynamics
7.4.5.3. Regulatory Framework
7.4.5.4. Reimbursement Scenario
7.4.5.5. Competitive Scenario
7.4.6. Thailand
7.4.6.1. Thailand Pan-Genomic & Multi-Gene Panel Testing Market, 2021 - 2033 (USD Million)
7.4.6.2. Key Country Dynamics
7.4.6.3. Regulatory Framework
7.4.6.4. Reimbursement Scenario
7.4.6.5. Competitive Scenario
7.4.7. Australia
7.4.7.1. Australia Pan-Genomic & Multi-Gene Panel Testing Market, 2021 - 2033 (USD Million)
7.4.7.2. Key Country Dynamics
7.4.7.3. Regulatory Framework
7.4.7.4. Reimbursement Scenario
7.4.7.5. Competitive Scenario
7.5. Latin America
7.5.1. Latin America Pan-Genomic & Multi-Gene Panel Testing Market, 2021 - 2033 (USD Million)
7.5.2. Brazil
7.5.2.1. Brazil Pan-Genomic & Multi-Gene Panel Testing Market, 2021 - 2033 (USD Million)
7.5.2.2. Key Country Dynamics
7.5.2.3. Regulatory Framework
7.5.2.4. Reimbursement Scenario
7.5.2.5. Competitive Scenario
7.5.3. Argentina
7.5.3.1. Argentina Pan-Genomic & Multi-Gene Panel Testing Market, 2021 - 2033 (USD Million)
7.5.3.2. Key Country Dynamics
7.5.3.3. Regulatory Framework
7.5.3.4. Reimbursement Scenario
7.5.3.5. Competitive Scenario
7.6. MEA
7.6.1. MEA Pan-Genomic & Multi-Gene Panel Testing Market, 2021 - 2033 (USD Million)
7.6.2. South Africa
7.6.2.1. South Africa Pan-Genomic & Multi-Gene Panel Testing Market, 2021 - 2033 (USD Million)
7.6.2.2. Key Country Dynamics
7.6.2.3. Regulatory Framework
7.6.2.4. Reimbursement Scenario
7.6.2.5. Competitive Scenario
7.6.3. Saudi Arabia
7.6.3.1. Saudi Arabia Pan-Genomic & Multi-Gene Panel Testing Market, 2021 - 2033 (USD Million)
7.6.3.2. Key Country Dynamics
7.6.3.3. Regulatory Framework
7.6.3.4. Reimbursement Scenario
7.6.3.5. Competitive Scenario
7.6.4. UAE
7.6.4.1. UAE Pan-Genomic & Multi-Gene Panel Testing Market, 2021 - 2033 (USD Million)
7.6.4.2. Key Country Dynamics
7.6.4.3. Regulatory Framework
7.6.4.4. Reimbursement Scenario
7.6.4.5. Competitive Scenario
7.6.5. Kuwait
7.6.5.1. Kuwait Pan-Genomic & Multi-Gene Panel Testing Market, 2021 - 2033 (USD Million)
7.6.5.2. Key Country Dynamics
7.6.5.3. Regulatory Framework
7.6.5.4. Reimbursement Scenario
7.6.5.5. Competitive Scenario

Chapter 8. Competitive Landscape
8.1. Company Categorization
8.2. Strategy Mapping
8.2.1. New Product Launch
8.2.2. Partnerships
8.2.3. Acquisition
8.2.4. Collaboration
8.2.5. Funding
8.3. Key Company Market Share Analysis, 2024
8.4. Company Heat Map Analysis
8.5. Company Profiles
8.5.1. Illumina, Inc.
8.5.1.1. Company Overview
8.5.1.2. Financial Performance
8.5.1.3. Product Benchmarking
8.5.1.4. Strategic Initiatives
8.5.2. Thermo Fisher Scientific, Inc.
8.5.2.1. Company Overview
8.5.2.2. Financial Performance
8.5.2.3. Product Benchmarking
8.5.2.4. Strategic Initiatives
8.5.3. Fulgent Genetics
8.5.3.1. Company Overview
8.5.3.2. Financial Performance
8.5.3.3. Product Benchmarking
8.5.3.4. Strategic Initiatives
8.5.4. Ambry Genetics (Tempus)
8.5.4.1. Company Overview
8.5.4.2. Financial Performance
8.5.4.3. Product Benchmarking
8.5.4.4. Strategic Initiatives
8.5.5. GeneDx
8.5.5.1. Company Overview
8.5.5.2. Financial Performance
8.5.5.3. Product Benchmarking
8.5.5.4. Strategic Initiatives
8.5.6. Baylor Genetics
8.5.6.1. Company Overview
8.5.6.2. Financial Performance
8.5.6.3. Product Benchmarking
8.5.6.4. Strategic Initiatives
8.5.7. Natera
8.5.7.1. Company Overview
8.5.7.2. Financial Performance
8.5.7.3. Product Benchmarking
8.5.7.4. Strategic Initiatives
8.5.8. Caris Life Sciences
8.5.8.1. Company Overview
8.5.8.2. Financial Performance
8.5.8.3. Product Benchmarking
8.5.8.4. Strategic Initiatives
8.5.9. Foundation Medicine, Inc. (Roche)
8.5.9.1. Company Overview
8.5.9.2. Financial Performance
8.5.9.3. Product Benchmarking
8.5.9.4. Strategic Initiatives
8.5.10. Guardant Health
8.5.10.1. Company Overview
8.5.10.2. Financial Performance
8.5.10.3. Product Benchmarking
8.5.10.4. Strategic Initiatives
List of Tables
Table 1 List Of Secondary Sources
Table 2 List Of Abbreviation
Table 3 Global Pan-Genomic & Multi-Gene Panel Testing Market, By Region, 2021 - 2033 (USD Million)
Table 4 Global Pan-Genomic & Multi-Gene Panel Testing Market, By Test, 2021 - 2033 (USD Million)
Table 5 Global Pan-Genomic & Multi-Gene Panel Testing Market, By Application, 2021 - 2033 (USD Million)
Table 6 Global Pan-Genomic & Multi-Gene Panel Testing Market, By End Use, 2021 - 2033 (USD Million)
Table 7 North America Pan-Genomic & Multi-Gene Panel Testing Market, By Country, 2021 - 2033 (USD Million)
Table 8 North America Pan-Genomic & Multi-Gene Panel Testing Market, By Test, 2021 - 2033 (USD Million)
Table 9 North America Pan-Genomic & Multi-Gene Panel Testing Market, By Application, 2021 - 2033 (USD Million)
Table 10 North America Pan-Genomic & Multi-Gene Panel Testing Market, By End Use, 2021 - 2033 (USD Million)
Table 11 U.S. Pan-Genomic & Multi-Gene Panel Testing Market, By Test, 2021 - 2033 (USD Million)
Table 12 U.S. Pan-Genomic & Multi-Gene Panel Testing Market, By Application, 2021 - 2033 (USD Million)
Table 13 U.S. Pan-Genomic & Multi-Gene Panel Testing Market, By End Use, 2021 - 2033 (USD Million)
Table 14 Canada Pan-Genomic & Multi-Gene Panel Testing Market, By Test, 2021 - 2033 (USD Million)
Table 15 Canada Pan-Genomic & Multi-Gene Panel Testing Market, By Application, 2021 - 2033 (USD Million)
Table 16 Canada Pan-Genomic & Multi-Gene Panel Testing Market, By End Use, 2021 - 2033 (USD Million)
Table 17 Mexico Pan-Genomic & Multi-Gene Panel Testing Market, By Test, 2021 - 2033 (USD Million)
Table 18 Mexico Pan-Genomic & Multi-Gene Panel Testing Market, By Application, 2021 - 2033 (USD Million)
Table 19 Mexico Pan-Genomic & Multi-Gene Panel Testing Market, By End Use, 2021 - 2033 (USD Million)
Table 20 Europe Pan-Genomic & Multi-Gene Panel Testing Market, By Country, 2021 - 2033 (USD Million)
Table 21 Europe Pan-Genomic & Multi-Gene Panel Testing Market, By Test, 2021 - 2033 (USD Million)
Table 22 Europe Pan-Genomic & Multi-Gene Panel Testing Market, By Application, 2021 - 2033 (USD Million)
Table 23 Europe Pan-Genomic & Multi-Gene Panel Testing Market, By End Use, 2021 - 2033 (USD Million)
Table 24 UK Pan-Genomic & Multi-Gene Panel Testing Market, By Test, 2021 - 2033 (USD Million)
Table 25 UK Pan-Genomic & Multi-Gene Panel Testing Market, By Application, 2021 - 2033 (USD Million)
Table 26 UK Pan-Genomic & Multi-Gene Panel Testing Market, By End Use, 2021 - 2033 (USD Million)
Table 27 Germany Pan-Genomic & Multi-Gene Panel Testing Market, By Test, 2021 - 2033 (USD Million)
Table 28 Germany Pan-Genomic & Multi-Gene Panel Testing Market, By Application, 2021 - 2033 (USD Million)
Table 29 Germany Pan-Genomic & Multi-Gene Panel Testing Market, By End Use, 2021 - 2033 (USD Million)
Table 30 France Pan-Genomic & Multi-Gene Panel Testing Market, By Test, 2021 - 2033 (USD Million)
Table 31 France Pan-Genomic & Multi-Gene Panel Testing Market, By Application, 2021 - 2033 (USD Million)
Table 32 France Pan-Genomic & Multi-Gene Panel Testing Market, By End Use, 2021 - 2033 (USD Million)
Table 33 Italy Pan-Genomic & Multi-Gene Panel Testing Market, By Test, 2021 - 2033 (USD Million)
Table 34 Italy Pan-Genomic & Multi-Gene Panel Testing Market, By Application, 2021 - 2033 (USD Million)
Table 35 Italy Pan-Genomic & Multi-Gene Panel Testing Market, By End Use, 2021 - 2033 (USD Million)
Table 36 Spain Pan-Genomic & Multi-Gene Panel Testing Market, By Test, 2021 - 2033 (USD Million)
Table 37 Spain Pan-Genomic & Multi-Gene Panel Testing Market, By Application, 2021 - 2033 (USD Million)
Table 38 Spain Pan-Genomic & Multi-Gene Panel Testing Market, By End Use, 2021 - 2033 (USD Million)
Table 39 Sweden Pan-Genomic & Multi-Gene Panel Testing Market, By Test, 2021 - 2033 (USD Million)
Table 40 Sweden Pan-Genomic & Multi-Gene Panel Testing Market, By Application, 2021 - 2033 (USD Million)
Table 41 Sweden Pan-Genomic & Multi-Gene Panel Testing Market, By End Use, 2021 - 2033 (USD Million)
Table 42 Norway Pan-Genomic & Multi-Gene Panel Testing Market, By Test, 2021 - 2033 (USD Million)
Table 43 Norway Pan-Genomic & Multi-Gene Panel Testing Market, By Application, 2021 - 2033 (USD Million)
Table 44 Norway Pan-Genomic & Multi-Gene Panel Testing Market, By End Use, 2021 - 2033 (USD Million)
Table 45 Denmark Pan-Genomic & Multi-Gene Panel Testing Market, By Test, 2021 - 2033 (USD Million)
Table 46 Denmark Pan-Genomic & Multi-Gene Panel Testing Market, By Application, 2021 - 2033 (USD Million)
Table 47 Denmark Pan-Genomic & Multi-Gene Panel Testing Market, By End Use, 2021 - 2033 (USD Million)
Table 48 Asia Pacific Pan-Genomic & Multi-Gene Panel Testing Market, By Country, 2021 - 2033 (USD Million)
Table 49 Asia Pacific Pan-Genomic & Multi-Gene Panel Testing Market, By Test, 2021 - 2033 (USD Million)
Table 50 Asia-Pacific Pan-Genomic & Multi-Gene Panel Testing Market, By Application, 2021 - 2033 (USD Million)
Table 51 Asia Pacific Pan-Genomic & Multi-Gene Panel Testing Market, By End Use, 2021 - 2033 (USD Million)
Table 52 Japan Pan-Genomic & Multi-Gene Panel Testing Market, By Test, 2021 - 2033 (USD Million)
Table 53 Japan Pan-Genomic & Multi-Gene Panel Testing Market, By Application, 2021 - 2033 (USD Million)
Table 54 Japan Pan-Genomic & Multi-Gene Panel Testing Market, By End Use, 2021 - 2033 (USD Million)
Table 55 China Pan-Genomic & Multi-Gene Panel Testing Market, By Test, 2021 - 2033 (USD Million)
Table 56 China Pan-Genomic & Multi-Gene Panel Testing Market, By Application, 2021 - 2033 (USD Million)
Table 57 China Pan-Genomic & Multi-Gene Panel Testing Market, By End Use, 2021 - 2033 (USD Million)
Table 58 India Pan-Genomic & Multi-Gene Panel Testing Market, By Test, 2021 - 2033 (USD Million)
Table 59 India Pan-Genomic & Multi-Gene Panel Testing Market, By Application, 2021 - 2033 (USD Million)
Table 60 India Pan-Genomic & Multi-Gene Panel Testing Market, By End Use, 2021 - 2033 (USD Million)
Table 61 Australia Pan-Genomic & Multi-Gene Panel Testing Market, By Test, 2021 - 2033 (USD Million)
Table 62 Australia Pan-Genomic & Multi-Gene Panel Testing Market, By Application, 2021 - 2033 (USD Million)
Table 63 Australia Pan-Genomic & Multi-Gene Panel Testing Market, By End Use, 2021 - 2033 (USD Million)
Table 64 Thailand Pan-Genomic & Multi-Gene Panel Testing Market, By Test, 2021 - 2033 (USD Million)
Table 65 Thailand Pan-Genomic & Multi-Gene Panel Testing Market, By Application, 2021 - 2033 (USD Million)
Table 66 Thailand Pan-Genomic & Multi-Gene Panel Testing Market, By End Use, 2021 - 2033 (USD Million)
Table 67 South Korea Pan-Genomic & Multi-Gene Panel Testing Market, By Test, 2021 - 2033 (USD Million)
Table 68 South Korea Pan-Genomic & Multi-Gene Panel Testing Market, By Application, 2021 - 2033 (USD Million)
Table 69 South Korea Pan-Genomic & Multi-Gene Panel Testing Market, By End Use, 2021 - 2033 (USD Million)
Table 70 Latin America Pan-Genomic & Multi-Gene Panel Testing Market, By Country, 2021 - 2033 (USD Million)
Table 71 Latin America Pan-Genomic & Multi-Gene Panel Testing Market, By Test, 2021 - 2033 (USD Million)
Table 72 Latin America Pan-Genomic & Multi-Gene Panel Testing Market, By Application, 2021 - 2033 (USD Million)
Table 73 Latin America Pan-Genomic & Multi-Gene Panel Testing Market, By End Use, 2021 - 2033 (USD Million)
Table 74 Brazil Pan-Genomic & Multi-Gene Panel Testing Market, By Test, 2021 - 2033 (USD Million)
Table 75 Brazil Pan-Genomic & Multi-Gene Panel Testing Market, By Application, 2021 - 2033 (USD Million)
Table 76 Brazil Pan-Genomic & Multi-Gene Panel Testing Market, By End Use, 2021 - 2033 (USD Million)
Table 77 Argentina Pan-Genomic & Multi-Gene Panel Testing Market, By Test, 2021 - 2033 (USD Million)
Table 78 Argentina Pan-Genomic & Multi-Gene Panel Testing Market, By Application, 2021 - 2033 (USD Million)
Table 79 Argentina Pan-Genomic & Multi-Gene Panel Testing Market, By End Use, 2021 - 2033 (USD Million)
Table 80 MEA Pan-Genomic & Multi-Gene Panel Testing Market, By Country, 2021 - 2033 (USD Million)
Table 81 MEA Pan-Genomic & Multi-Gene Panel Testing Market, By Test, 2021 - 2033 (USD Million)
Table 82 MEA Pan-Genomic & Multi-Gene Panel Testing Market, By Application, 2021 - 2033 (USD Million)
Table 83 MEA Pan-Genomic & Multi-Gene Panel Testing Market, By End Use, 2021 - 2033 (USD Million)
Table 84 South Africa Pan-Genomic & Multi-Gene Panel Testing Market, By Test, 2021 - 2033 (USD Million)
Table 85 South Africa Pan-Genomic & Multi-Gene Panel Testing Market, By Application, 2021 - 2033 (USD Million)
Table 86 South Africa Pan-Genomic & Multi-Gene Panel Testing Market, By End Use, 2021 - 2033 (USD Million)
Table 87 Saudi Arabia Pan-Genomic & Multi-Gene Panel Testing Market, By Test, 2021 - 2033 (USD Million)
Table 88 Saudi Arabia Pan-Genomic & Multi-Gene Panel Testing Market, By Application, 2021 - 2033 (USD Million)
Table 89 Saudi Arabia Pan-Genomic & Multi-Gene Panel Testing Market, By End Use, 2021 - 2033 (USD Million)
Table 90 UAE Pan-Genomic & Multi-Gene Panel Testing Market, By Test, 2021 - 2033 (USD Million)
Table 91 UAE Pan-Genomic & Multi-Gene Panel Testing Market, By Application, 2021 - 2033 (USD Million)
Table 92 UAE Pan-Genomic & Multi-Gene Panel Testing Market, By End Use, 2021 - 2033 (USD Million)
Table 93 Kuwait Pan-Genomic & Multi-Gene Panel Testing Market, By Test, 2021 - 2033 (USD Million)
Table 94 Kuwait Pan-Genomic & Multi-Gene Panel Testing Market, By Application, 2021 - 2033 (USD Million)
Table 95 Kuwait Pan-Genomic & Multi-Gene Panel Testing Market, By End Use, 2021 - 2033 (USD Million)
List of Figures
Fig. 1 Pan-genomic & multi-gene panel testing market segmentation
Fig. 2 Data analysis test technique
Fig. 3 Market formulation and validation
Fig. 4 Data validating & publishing
Fig. 5 Market research process
Fig. 6 Information procurement
Fig. 7 Primary research
Fig. 8 Value-chain-based sizing & forecasting
Fig. 9 QFD biomarker modelling for market share assessment
Fig. 10 Market formulation & validation
Fig. 11 Commodity flow analysis
Fig. 12 Market outlook
Fig. 13 Segment snapshot-1
Fig. 14 Segment snapshot-2
Fig. 15 Competitive landscape snapshot
Fig. 16 Market trends & outlook
Fig. 17 Porter’s five force analysis
Fig. 18 PESTEL analysis
Fig. 19 Pan-genomic & multi-gene panel testing market Test outlook key takeaways
Fig. 20 Pan-genomic & multi-gene panel testing market: Test movement analysis
Fig. 21 Pan-genomic / whole exome based panels market estimates, 2021 - 2033 (USD Million)
Fig. 22 Comprehensive hereditary disease panels market estimates, 2021 - 2033 (USD Million)
Fig. 23 Oncology multi-gene panels market estimates, 2021 - 2033 (USD Million)
Fig. 24 Pharmacogenomics (PGx) panels market estimates, 2021 - 2033 (USD Million)
Fig. 25 Pan-genomic & multi-gene panel testing market: Application outlook key takeaways
Fig. 26 Pan-genomic & multi-gene panel testing market: Application movement analysis
Fig. 27 Oncology market estimates, 2021 - 2033 (USD Million)
Fig. 28 Cardiology & cardiomyopathy market estimates, 2021 - 2033 (USD Million)
Fig. 29 Neurology and neurogenetics market estimates, 2021 - 2033 (USD Million)
Fig. 30 Rare & undiagnosed genetic diseases market estimates, 2021 - 2033 (USD Million)
Fig. 31 Reproductive carrier screening market estimates, 2021 - 2033 (USD Million)
Fig. 32 Newborn & pediatric genomics market estimates, 2021 - 2033 (USD Million)
Fig. 33 Pan-genomic & multi-gene panel testing market: End Use outlook key takeaways
Fig. 34 Pan-genomic & multi-gene panel testing market: End Use movement analysis
Fig. 35 Hospital-based genetic labs market estimates, 2021 - 2033 (USD Million)
Fig. 36 Independent diagnostic labs market estimates, 2021 - 2033 (USD Million)
Fig. 37 Specialty genomic centers market estimates, 2021 - 2033 (USD Million)
Fig. 38 Others market estimates, 2021 - 2033 (USD Million)
Fig. 39 Regional marketplace: Key takeaways
Fig. 40 Middle East
Fig. 41 Middle East market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 42 Saudi Arabia key country dynamics
Fig. 43 Saudi Arabia market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 44 UAE key country dynamics
Fig. 45 UAE market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 46 Kuwait key country dynamics
Fig. 47 Kuwait market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 48 Oman key country dynamics
Fig. 49 Oman market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 50 Qatar key country dynamics
Fig. 51 Qatar market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 52 Rest of Middle East key country dynamics
Fig. 53 Rest of Middle East market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 54 Market differentiators
Fig. 55 Key company market share analysis